Neuropace, Inc. Common Stock
€14.68
EUR
Last updated on --.
24h volume126.84K
24h highest14.7403 EUR
24h lowest14.2846 EUR
24h Price movement+2.40%
NPCE recent prices
24 Hours
+2.40%+€0.344
30 days
+1.10%+€0.1591
60 days
+32.98%+€3.642
90 days
+17.11%+€2.145
Key data
Previous close14.3448 EUR
Market cap477.05M EUR
Volume126.84K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.54180 EUR
Net income (FY)-18.55M EUR
Revenue (FY)85.60M EUR
Last report dateMay 12, 2026
About Neuropace, Inc. Common Stock
HeadquartersMOUNTAIN VIEW
Employees (FY)220.00
Revenue per employee (FY)389.07K EUR
Net income per employee (FY)-84.30K EUR
Listed onNasdaq
NPCE conversion tables
 |  |
|---|---|
| 0.5 NPCE | 7.344 EUR |
| 1 NPCE | 14.68 EUR |
| 5 NPCE | 73.44 EUR |
| 10 NPCE | 146.88 EUR |
| |
|---|---|
| 0.5 EUR | 0.03404 NPCE |
| 1 EUR | 0.068079 NPCE |
| 5 EUR | 0.3404 NPCE |
| 10 EUR | 0.68079 NPCE |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
NPCE is trading at €14.68, +2.40% over the last 24 hours. Track live moves on the price chart at the top of this page.
The NPCE stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. NPCE is currently trading at €14.68, +2.40% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on NPCE price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. NPCE's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from NPCE; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against NPCE's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Neuropace, Inc. Common Stock's market cap is currently 477.05M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume126.84K
24h highest14.7403 EUR
24h lowest14.2846 EUR
24h Price movement+2.40%
Start trade with NPCE Perpetual
Sign up to trade